Recent structural investigation of amyloid filaments extracted from human patients demonstrated that the ex vivo filaments associated with different disease phenotypes adopt diverse molecular conformations, which are different from those of in vitro amyloid filaments. A very recent cryo-EM structural study also revealed that ex vivo α-synuclein filaments extracted from multiple system atrophy patients adopt distinct molecular structures from those of in vitro α-synuclein filaments, suggesting the presence of co-factors for α-synuclein aggregation in vivo. Here, we report structural characterizations of α-synuclein filaments formed in the presence of a potential co-factor, tau, using cryo-EM and solid-state NMR. Our cryo-EM structure of the ...
Misfolding and self-association of peptides and proteins resulting in aggregates denoted as amyloid ...
Fibrillar aggregates of Aβ and Tau in the brain are the major hallmarks of Alzheimer’s disease. Most...
Parkinson's disease (PD) and Multiple System Atrophy (MSA) are clinically distinctive diseases that ...
Multiple neurodegenerative diseases, including Parkinson's disease (PD), dementia with Lewy bodies (...
Synucleinopathies, which include multiple system atrophy (MSA), Parkinson's disease, Parkinson's dis...
Abnormal accumulation of aggregated α-synuclein (α-Syn) is seen in a variety of neurodegenerative di...
Parkinson’s disease is a neurological human proteinopathy, which is caused by the accumulation of pr...
The ordered assembly of tau protein into abnormal filamentous inclusions underlies many human neurod...
Misfolded a-synuclein amyloid fibrils are the principal components of Lewy bodies and neurites, hall...
Lewy bodies are intracytoplasmic aggregates that are the major pathological feature of Parkinson’s d...
Deposits of amyloid fibrils of α-synuclein are the histological hallmarks of Parkinson's disease, de...
International audienceTau is a microtubule-associated protein involved in the regulation of axonal m...
Aggregation of the tau protein into fibrillar cross-β aggregates is a hallmark of Alzheimer’s diseas...
The discovery of β-sheet structure in Alzheimer's amyloid fibrils, and then in many other disease-re...
The accumulation of tau fibrils is associated with neurodegenerative diseases, which are collectivel...
Misfolding and self-association of peptides and proteins resulting in aggregates denoted as amyloid ...
Fibrillar aggregates of Aβ and Tau in the brain are the major hallmarks of Alzheimer’s disease. Most...
Parkinson's disease (PD) and Multiple System Atrophy (MSA) are clinically distinctive diseases that ...
Multiple neurodegenerative diseases, including Parkinson's disease (PD), dementia with Lewy bodies (...
Synucleinopathies, which include multiple system atrophy (MSA), Parkinson's disease, Parkinson's dis...
Abnormal accumulation of aggregated α-synuclein (α-Syn) is seen in a variety of neurodegenerative di...
Parkinson’s disease is a neurological human proteinopathy, which is caused by the accumulation of pr...
The ordered assembly of tau protein into abnormal filamentous inclusions underlies many human neurod...
Misfolded a-synuclein amyloid fibrils are the principal components of Lewy bodies and neurites, hall...
Lewy bodies are intracytoplasmic aggregates that are the major pathological feature of Parkinson’s d...
Deposits of amyloid fibrils of α-synuclein are the histological hallmarks of Parkinson's disease, de...
International audienceTau is a microtubule-associated protein involved in the regulation of axonal m...
Aggregation of the tau protein into fibrillar cross-β aggregates is a hallmark of Alzheimer’s diseas...
The discovery of β-sheet structure in Alzheimer's amyloid fibrils, and then in many other disease-re...
The accumulation of tau fibrils is associated with neurodegenerative diseases, which are collectivel...
Misfolding and self-association of peptides and proteins resulting in aggregates denoted as amyloid ...
Fibrillar aggregates of Aβ and Tau in the brain are the major hallmarks of Alzheimer’s disease. Most...
Parkinson's disease (PD) and Multiple System Atrophy (MSA) are clinically distinctive diseases that ...